Glomerular VEGF resistance induced by PKCδ/SHP-1 activation and contribution to diabetic nephropathy.
about
Targeting inflammation in diabetes: Newer therapeutic optionsInflammation and oxidative stress in diabetic nephropathy: new insights on its inhibition as new therapeutic targetsMicroRNA-29a promotion of nephrin acetylation ameliorates hyperglycemia-induced podocyte dysfunction.Increased SHP-1 protein expression by high glucose levels reduces nephrin phosphorylation in podocytesVascular complications of diabetes: mechanisms of injury and protective factorsMinimal change disease onset observed after bevacizumab administration.Immunopathogenesis of idiopathic nephrotic syndrome with relapse.Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction.Expression of SHP-1 induced by hyperglycemia prevents insulin actions in podocytes.Regulation of Nephrin Phosphorylation in Diabetes and Chronic Kidney Injury.Effect of NADPH oxidase inhibitor-apocynin on the expression of Src homology-2 domain-containing phosphatase-1 (SHP-1) exposed renal ischemia/reperfusion injury in rats.Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.SHP-1 activation inhibits vascular smooth muscle cell proliferation and intimal hyperplasia in a rodent model of insulin resistance and diabetes.Blood glucose fluctuation accelerates renal injury involved to inhibit the AKT signaling pathway in diabetic rats.Obesity-associated glomerular inflammation increases albuminuria without renal histological changes.Methotrexate induced pneumatosis intestinalis under hemodialysis patient.Oxidative Stress, Apoptosis, and Mitochondrial Function in Diabetic Nephropathy.Nephrin Signaling in the Podocyte: An Updated View of Signal Regulation at the Slit Diaphragm and Beyond.
P2860
Q26852726-D057692E-D215-402D-9882-D0D37B6E8659Q26866480-02BA627C-4D1B-4D00-AF2A-2EF7D98D1003Q33974555-4112E427-480B-4ABE-A97D-9390A085E787Q34801482-7571D5CC-E955-4C2E-A1AB-0A860D6E5FCEQ36537262-E1C8C030-EDBB-4FE8-ACDD-444ACC6C5A97Q36689167-FB3C9CA9-1D03-4C2F-959D-2DCAF9A66673Q37742644-CC6750FE-9674-44AE-B00A-062B515C0478Q38706335-29D46687-DB96-4442-A99C-CEBD60A529E4Q39175261-48B8D34D-13E8-4037-BA92-469F1056DC44Q39390200-6D4E2ABB-5947-429D-8A2A-3D99B963AEFFQ41680035-82F18973-514E-4533-92A4-45FB198EE2D1Q45072634-E7581277-F513-4ABF-931B-9F52BF742C49Q48909084-E5C69C25-302C-435B-9648-D042D8538914Q53179601-6A04C005-7B40-4AEE-B120-7887691BB679Q53831433-B02CE4EF-1522-4273-92B8-F0666464EA71Q54379575-53B479A1-9FAD-40E9-9C52-7EA0A8A19334Q54977897-A632BE1B-FE1F-4ADD-89CD-56808D849216Q55376726-A348E01E-9046-49B8-ADE5-EB2DD4BC8EF2
P2860
Glomerular VEGF resistance induced by PKCδ/SHP-1 activation and contribution to diabetic nephropathy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Glomerular VEGF resistance ind ...... ution to diabetic nephropathy.
@ast
Glomerular VEGF resistance ind ...... ution to diabetic nephropathy.
@en
type
label
Glomerular VEGF resistance ind ...... ution to diabetic nephropathy.
@ast
Glomerular VEGF resistance ind ...... ution to diabetic nephropathy.
@en
prefLabel
Glomerular VEGF resistance ind ...... ution to diabetic nephropathy.
@ast
Glomerular VEGF resistance ind ...... ution to diabetic nephropathy.
@en
P2093
P2860
P356
P1433
P1476
Glomerular VEGF resistance ind ...... ution to diabetic nephropathy.
@en
P2093
Akira Mima
Chenzhong Li
Christian Rask-Madsen
George L King
Koji Mizutani
Michael Leitges
Motonobu Matsumoto
Munehiro Kitada
Pedro Geraldes
P2860
P304
P356
10.1096/FJ.11-202994
P407
P577
2012-04-12T00:00:00Z